106 related articles for article (PubMed ID: 15528890)
41. Changes in vancomycin-resistant Enterococcus faecium causing outbreaks in Brazil.
Palazzo IC; Pitondo-Silva A; Levy CE; da Costa Darini AL
J Hosp Infect; 2011 Sep; 79(1):70-4. PubMed ID: 21741112
[TBL] [Abstract][Full Text] [Related]
42. High-level gentamicin-resistant Enterococcus faecium strains isolated from bone marrow transplant patients: accumulation of antibiotic resistance genes, large plasmids and clonal strain dissemination.
Abbassi MS; Achour W; Hassen AB
Int J Antimicrob Agents; 2007 Jun; 29(6):658-64. PubMed ID: 17360161
[TBL] [Abstract][Full Text] [Related]
43. Virulence and antimicrobial resistance in clinical Enterococcus faecium.
Billström H; Lund B; Sullivan A; Nord CE
Int J Antimicrob Agents; 2008 Nov; 32(5):374-7. PubMed ID: 18715765
[TBL] [Abstract][Full Text] [Related]
44. Occurrence and spread of antibiotic resistances in Enterococcus faecium.
Klare I; Konstabel C; Badstübner D; Werner G; Witte W
Int J Food Microbiol; 2003 Dec; 88(2-3):269-90. PubMed ID: 14597000
[TBL] [Abstract][Full Text] [Related]
45. High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17).
Werner G; Fleige C; Ewert B; Laverde-Gomez JA; Klare I; Witte W
Int J Antimicrob Agents; 2010 Feb; 35(2):119-25. PubMed ID: 20006472
[TBL] [Abstract][Full Text] [Related]
46. [Molecular characterization of vancomycin-resistant enterococci isolates].
Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of resistance to daptomycin in Enterococcus faecium.
Montero CI; Stock F; Murray PR
Antimicrob Agents Chemother; 2008 Mar; 52(3):1167-70. PubMed ID: 18180351
[TBL] [Abstract][Full Text] [Related]
48. Resistance patterns and occurrence of virulence determinants among GRE strains in southwestern Poland.
Kowalska-Krochmal B; Dworniczek E; Dolna I; Bania J; Wałecka E; Seniuk A; Gościniak G
Adv Med Sci; 2011; 56(2):304-10. PubMed ID: 21940270
[TBL] [Abstract][Full Text] [Related]
49. The use of high-throughput sequencing to investigate an outbreak of glycopeptide-resistant Enterococcus faecium with a novel quinupristin-dalfopristin resistance mechanism.
Shaw TD; Fairley DJ; Schneiders T; Pathiraja M; Hill RLR; Werner G; Elborn JS; McMullan R
Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):959-967. PubMed ID: 29478197
[TBL] [Abstract][Full Text] [Related]
50. Commensal and environmental vancomycin-resistant Enterococcus faecium isolated in hospital settings: genotypic diversity, antimicrobial resistance and virulence traits.
Gomes LV; Morey AT; Santos JP; Cardoso JD; Oliveira CF; Perugini MR; Yamauchi LM; Ogatta SF
Indian J Med Microbiol; 2014; 32(3):345-7. PubMed ID: 25008838
[No Abstract] [Full Text] [Related]
51. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit.
Chadwick PR; Oppenheim BA; Fox A; Woodford N; Morgenstern GR; Scarffe JH
J Hosp Infect; 1996 Nov; 34(3):171-82. PubMed ID: 8923271
[TBL] [Abstract][Full Text] [Related]
52. Clonality among Enterococcus faecium clinical isolates.
Baldassarri L; Bertuccini L; Creti R; Orefici G; Dicuonzo G; Gherardi G; Venditti M; Di Rosa R
Microb Drug Resist; 2005; 11(2):141-5. PubMed ID: 15910228
[TBL] [Abstract][Full Text] [Related]
53. Clonal spread of vanA Enterococcus faecium sequence type 203 in Bulgarian hospitals.
Strateva T; Sirakov I; Dimov S; Trifonova A; Savov E; Mitov I
Infect Dis (Lond); 2018 Sep; 50(9):718-721. PubMed ID: 29558857
[No Abstract] [Full Text] [Related]
54. First report of ampicillin and glycopeptide resistant Enterococcus faecium VanA bacteraemia in Greece.
Kouppari G; Papadaki H; Arida C; Sakellariou J; Legakis NJ; Papaparaskevas J
Int J Antimicrob Agents; 2000 Nov; 16(3):254-6. PubMed ID: 11185546
[No Abstract] [Full Text] [Related]
55. Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen.
Gao W; Howden BP; Stinear TP
Curr Opin Microbiol; 2018 Feb; 41():76-82. PubMed ID: 29227922
[TBL] [Abstract][Full Text] [Related]
56. Detection in Greece of a clinical Enterococcus faecium isolate carrying the novel oxazolidinone resistance gene poxtA.
Papagiannitsis CC; Tsilipounidaki K; Malli E; Petinaki E
J Antimicrob Chemother; 2019 Aug; 74(8):2461-2462. PubMed ID: 31009054
[No Abstract] [Full Text] [Related]
57. First emergence of glycopeptide-resistant enterococci infections in Greece.
Routsi C; Platsouka E; Armaganidis A; Paniara O; Roussos C
Scand J Infect Dis; 2001; 33(1):80. PubMed ID: 11234989
[No Abstract] [Full Text] [Related]
58. Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins.
Descheemaeker PR; Chapelle S; Devriese LA; Butaye P; Vandamme P; Goossens H
Antimicrob Agents Chemother; 1999 Aug; 43(8):2032-7. PubMed ID: 10428931
[TBL] [Abstract][Full Text] [Related]
59. Characterization of glycopeptide-resistant enterococcus faecium (GRE) from broilers and pigs in Denmark: genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides.
Aarestrup FM
J Clin Microbiol; 2000 Jul; 38(7):2774-7. PubMed ID: 10878086
[TBL] [Abstract][Full Text] [Related]
60. Molecular epidemiology of glycopeptide-resistant Enterococcus faecium on a renal unit.
Chadwick PR; Fox A; Woodford N
Epidemiol Infect; 1997 Oct; 119(2):159-66. PubMed ID: 9363014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
